Covance, a global contract research organization, worked on all of the top 50 best-selling drugs available today through its full spectrum of nonclinical, clinical and commercialization services.
Covance is dedicated to advancing healthcare and delivering Solutions Made Real®
With precision delivery of the largest volume of drug development data on the planet, we can help you identify new approaches and anticipate tomorrow’s challenges. Learn more about our history and services.
Meet Covance at the Society of Toxicology (SOT) Anaheim, CA | March 15-19, 2020 | Booth #503
Get your questions ready and visit us at Booth #503 to learn how our experienced team can help you to reduce risk and save time in your drug development journey.
Cell & Gene Therapy Solutions
Learn more about reducing time and risk in your therapeutic's development across pre-clinical, clinical and post-approval phases.
Hybrid and Virtual Trials
Connect with More Patients, Virtually Anywhere
Covance hybrid and virtual trials: Designed Around You® and your patients
Real-Time Data. Real-World Impact.
Combining four unique data sets with our therapeutic and functional expertise, Covance can impact protocol design and feasibility, optimal site selection, and patient recruitment.
Covance Builds on Extensive Cytometry Offering with Innovative Fluidigm CyTOF® Technology
Learn more about our comprehensive flow cytometry solutions
Register Now: Nonclinical Drug Development Symposium (6-7 May)
The Early Development Symposium will focus this year on biologics for cell and gene therapies and the use of primates in drug development. This two-day educational event that will be hosted in Germany on May 6-7 includes both presentations and interactive formats. Check out the agenda and speaker line-up to add this event to your 2020 list!
Accelerate Your Speed to Market with Scientific Support from the Biomarker Solution Center
Collaborate on a tailored approach to your biomarker program with a team of PhD-level leaders bringing expertise in key therapeutic areas.
Brexit: Leveraging the Mutual Recognition Agreement to Mitigate Potential Risk With Commercial Drug Product Release Testing
Fixing the Leaky Patient Recruitment Funnel
Watch now to learn innovative, data-driven approaches for improving patient recruitment and retention.
Tools & Technology for Advancing Rare Disease Research and Drug Development
Read about how the role of emerging science, technology and real-world data is allowing for exploring novel methods of data analysis.
Analytical methods for bioanalysis
Check out our recently updated nonproprietary assay list featuring more than 330 compounds.
Clinical Data and Informatics
Explore the Xcellerate® Informatics Suite
Successful clinical trials begin and end with the RIGHT data. Uncover new possibilities for your clinical trials with Xcellerate®, a fully integrated informatics platform. ONE comprehensive platform. UNPARALLELED RESULTS.
Bioanalysis Education Center: Covance leads the way in bioanalytical capabilities and solutions, igniting innovation with exceptional science and timely answers.
Access the latest scientific posters, list of non-proprietary/generic assays, publications and info sheets.
Immuno-oncology and the role of biomarkers, companion and complementary diagnostics
Learn more about how the use of a variety of biomarkers, companion diagnostics (CDx) and complementary diagnostics has powered the recent evolution of immunotherapies and their potential applications.
Webinars & Events
Do you love learning? View upcoming scientific and educational webinars as well as events and tradeshows where we will be attending or presenting.